Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robohogs who wrote (6024)	6/15/2002 11:38:14 AM
From: Rocky9	of 10280

On X, don't forget that SEPR increased the price at least once in the last year. The hospital usage continues to be the unknown. But from the known info, it continues to do great. On Clarinex, although it hasn't taken 100% of the Claritin market (for pills) as I thought it should given the price advantage, it still has exceeded the fears of many. Next year is the real test. But this quarter should be better than many estimates. Allegra continues do fine, both US and xUS. Together, revenue looks great. Next year, SEPR says that the expense side will be better. I hope that they are right. They haven't been real great on their predictions (except for X, and you can't blame them for SGP, LLY, etc.).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next